Navigation Links
Kendle International Inc. Increases Consideration Amount for Tender Offer and Consent Solicitation for Convertible Notes
Date:6/17/2011

recommendation is made as to whether holders of the securities should tender their securities or give their consent.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offering, solicitation or sale would be unlawful.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Kendle's focus is on innovative solutions that reduce cycle times for its customers and accelerate the delivery of life-enhancing products to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, Kendle offers experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet its customers' clinical development challenges. For more information, please visit.

Forward Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements relating to the proposed Merger between Kendle and INC, as defined above, and the expected timing and completion of the transaction. Words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," "will," "should," "may," and other similar expressions are intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of Kendle's management and involve a number of significant risks and uncertainties, many of which are difficult to predict and are generally beyond the control of Kendle. Actual results may differ materially from the results antici
'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Kendle to Present at the UBS Global Life Sciences Conference
2. Kendle Named to FORTUNE List of 100 Fastest-Growing Companies for 2008
3. Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations
4. Kendle Named a Best Place to Work in Greater Cincinnati
5. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
6. Kendle to Present at the 2008 Credit Suisse Health Care Conference
7. Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
8. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2008 Earnings and 2009 Guidance Release, Webcast and Conference Call
9. Kendle to Present at Upcoming Barclays Capital and Raymond James Conferences
10. Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine Notable People in R&D
11. Kendle to Host Conference Call to Discuss Revised 2009 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Emerson Resources ... that Dr. Charles Signorino, the Company’s Chief Executive Officer ... 2013 after 32 years of service. As part of ... current President, has been named as Dr. Signorino’s successor. ... the pharmaceutical industry, having made a significant contribution to ...
(Date:5/21/2013)... , May 21, 2013  Synthetic Biologics, Inc. (NYSE MKT: ... treatment of serious infectious diseases, announced today that ... nd Annual Marcum LLP MicroCap Conference on Thursday, May ... at the Grand Hyatt Hotel. Mr. Riley is scheduled to ... webcast of Synthetic Biologics, presentation can be accessed by logging ...
(Date:5/21/2013)... Bed bugs have become so widespread in ... many turn to chemical-based pesticides for help to completely get ... risks those solutions present, the company advised the public to ... , According to My Cleaning Products, chemical-based pesticides are ... be. It shared that the pests have already developed immunity ...
(Date:5/21/2013)... NANONEX CORPORATION, a pioneer and leading ... the successful delivery and installation of a new ... a major Japanese manufacturing company. ... nanoimprint lithography tool that has the ability to ... and types. Based on Nanonex inventions and proprietary ...
Breaking Biology Technology:Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2
... search for the next generation of semiconductors. Researchers ... National Laboratory (Berkeley Lab) and the University of ... of the semiconductor indium arsenide onto a silicon ... electronic properties. A member of the IIIV family ...
... announced the launch of the journal Advanced Energy ... publishing high impact research in energy-related materials. "Our ... solutions with this dedicated new journal," says Deputy Editor ... family is the ideal environment for reaching a broad ...
... 2010 Medizone International, Inc. (OTC Bulletin Board: ... into a common stock purchase agreement establishing a $10,000,000 equity ... is for a two-year term.  Under the terms of the ... 25% discount to the average closing bid price over a ...
Cached Biology Technology:Ultrathin alternative to silicon for future electronics 2Ultrathin alternative to silicon for future electronics 3Medizone International Secures $10,000,000 Funding Commitment 2Medizone International Secures $10,000,000 Funding Commitment 3
(Date:5/21/2013)... modifications, which alter the way genes function without ... detected in the blood of pregnant women during ... foretell depression in the weeks after giving birth, ... debilitating. , The findings of the small study ... the journal Molecular Psychiatry . , "Postpartum ...
(Date:5/20/2013)... COLUMBUS, Ohio New research suggests that a compound ... "superpower" to escape death. , By altering a ... re-educates cancer cells into normal cells that die as ... by inhibiting a process that would cause them to ... strict programming. This study in cells, led by Ohio ...
(Date:5/19/2013)... reports that white men and women of European descent ... and lesser toe deformities, including hammer or claw toe. ... the heritability of foot disorders in humansappear in ... Wiley on behalf of the American College of Rheumatology ... as 60% of older adults have foot disorders which ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3Blame your parents for bunion woes 2
... February 12, 2010 An international team of investigators ... for Medical Research), Nijmegen Centre for Molecular Life Sciences ... implicated in cancer metastasis, also plays a significant role ... The research was published on February 12 in the ...
... The great promise of induced pluripotent stem cells is that ... tricks as embryonic stem cells, but without the controversy. ... the Proceedings of the National Academy of Sciences ... morph into the cells of the brain has found that ...
... The American Association for the Advancement of Science (AAAS) ... the Department of Entomology at the University of Illinois ... Understanding of Science and Technology Award. Berenbaum was ... research on the world of insects with her inspirational ...
Cached Biology News:Researchers identify mechanism for Frank-Ter Haar syndrome 2Induced neural stem cells: Not quite ready for prime time 2Entomologist May R. Berenbaum wins Public Understanding of Science Award 2Entomologist May R. Berenbaum wins Public Understanding of Science Award 3
OptiBuffer is a fully optimised medium, designed for,the electroporation of eukaryotic cells. OptiBuffer,improves both transfection efficiencies and survival,rates over PBS or other standard culture...
...
... interferons are cytopathic effect inhibition assays, also known ... include; tissue culture supernatents; serum from PK studies ... unit is defined as the quantity of interferon ... of viral infection by 50%. All ...
... interferons are cytopathic effect inhibition assays, also known ... include; tissue culture supernatents; serum from PK studies ... unit is defined as the quantity of interferon ... of viral infection by 50%. All ...
Biology Products: